Pioneering Microbiome Therapeutics Research: Your Trusted CRO Partner

Pioneering Microbiome Therapeutics Research: Your Trusted CRO Partner

Welcome to Creative Biolabs, a leading Contract Research Organization (CRO) dedicated to accelerating innovation in Microbiome Therapeutics. In an era where the intricate world of microorganisms is revealing profound connections to human health and disease, we stand at the forefront, offering comprehensive research solutions to translate groundbreaking discoveries into life-changing therapies.

Get a Quote Now →
Fig.1 Detection of antifungal resistance. (Creative Biolabs Authorized)

Unveiling the Power of the Microbiome: An Overview of Microbiome Therapeutics

Fig.2 Antifungal drug testing. (Creative Biolabs Authorized)

The field of microbiome therapeutics is rapidly emerging as a transformative area in medicine, offering novel approaches to prevent, diagnose, and treat a wide range of diseases by modulating the body's microbial communities. It represents a significant departure from traditional pharmaceutical interventions, focusing instead on harnessing the power of the trillions of microorganisms that reside within and on us. This revolutionary field holds immense promise for treating a wide range of conditions, including inflammatory bowel disease, metabolic disorders, autoimmune diseases, neurological conditions, and infectious diseases, offering a new paradigm in precision medicine. The core of microbiome therapy is based on the understanding that the human microbiome - a complex ecosystem composed of bacteria, viruses, fungi, and other microorganisms - plays a key role in maintaining health and influencing disease susceptibility.

Next-Generation Probiotics (NGPs): Engineering Health from Within

Traditional probiotics have long been recognized for their health-promoting properties. However, the emergence of NGPs represents a significant leap forward. NGPs are precisely characterized live microbial strains, often single species or defined consortia, selected for their specific mechanisms of action and targeted therapeutic effects. Unlike broad-spectrum traditional probiotics, NGPs are developed with a deep understanding of their physiological impact, enabling highly targeted interventions for specific health challenges. Our expertise spans a wide range of microbial species and families that are at the forefront of Next-Generation Probiotic research. Click on the link below to learn more about our capabilities and the therapeutic potential of these fascinating microorganisms:

Gut Health and Metabolic Regulation

Akkermansia muciniphila

A promising candidate for obesity, diabetes, and inflammatory bowel diseases due to its role in gut barrier integrity and mucin degradation.

Anaerobutyricum soehngenii

Explores its role in butyrate production and potential impact on gut health and metabolic disorders.

Anaerostipes spp.

Research into these butyrate-producing bacteria and their implications for gut barrier function and inflammation.

Blautia spp.

Investigating their diverse metabolic activities and potential therapeutic applications in gut health and beyond.

Butyricicoccus pullicaecorum

Focuses on its strong butyrate-producing capabilities and potential for inflammatory bowel disease therapy.

Christensenella minuta

Research into this core gut bacterium linked to leanness and metabolic health.

Dysosmobacter welbionis

Exploring its unique metabolic contributions and potential for managing metabolic disorders.

Eubacterium hallii

Investigating its significant role in producing beneficial short-chain fatty acids like butyrate.

Faecalibacterium prausnitzii

A key commensal bacterium known for its anti-inflammatory properties and role in gut health.

Ruminococcus spp.

Research into their diverse metabolic functions and impact on gut microbiota composition and function.

Roseburia spp.

Delving into these prominent butyrate producers and their contributions to gut homeostasis.

Broad-Spectrum Beneficial Microbes & Commensals

Bacteroides spp.

Exploring the diverse metabolic capabilities and immunomodulatory effects of this prevalent gut genus.

Bifidobacterium spp.

A well-established genus of beneficial bacteria, we delve into new strains and their therapeutic applications.

Clostridium spp.

Research into beneficial Clostridium clusters involved in butyrate production and immune modulation.

Lactobacillus spp.

Investigating novel strains and their applications in various health areas, from gut to vaginal health.

Parabacteroides spp.

Researching their role in gut metabolic health and potential for modulating host immunity.

Pedioccus pentosaceus

Exploring its probiotic potential and applications in food fermentation and gut health.

Propionibacterium freudenreichii

Investigating its unique probiotic properties and role in producing beneficial propionate.

Streptococcus spp.

Research into non-pathogenic Streptococcus strains with probiotic potential, particularly in oral and gut health.

Targeted Interventions & Emerging Areas

Atopobium vaginae

Research focused on understanding and modulating this bacterium in the context of vaginal health.

Eggerthellaceae Family

Exploring the diverse members of this family and their potential impact on host health and disease.

Enterococcus spp.

Investigating specific strains of Enterococcus with probiotic properties and their applications.

Escherichia coli (Nissle 1917 & other beneficial strains)

Focus on the therapeutic potential of non-pathogenic E. coli strains in gut health.

Oxalobacter formigenes

Dedicated research into its role in oxalate degradation and potential for kidney stone prevention.

Prevotella copri

Investigating its complex and sometimes controversial role in gut health and inflammatory conditions.

Pathogen Research & Control

Salmonella

Our research capabilities also extend to understanding and mitigating the impact of important pathogens, supporting the development of novel anti-infective strategies.

Mechanism of Action of Microbiome Therapeutics

Microbiome therapy utilizes the power of the human microbiome to prevent and treat diseases. These therapies aim to restore health by rebalancing microbial ecosystems, modulating host-microbe interactions, or directly targeting specific problematic microbes.

  • Restoring Microbial Balance (Re-equilibration)
  • Modulating Host-Microbe Interactions
    • Metabolite Production (Postbiotics)
    • Immune System Modulation
    • Barrier Enhancement
  • Targeting Specific Pathogens or Dysbiotic Pathways
    • Prebiotics
    • Engineered Microbes (Live Biotherapeutics)
Fig.3 Development of antifungal drugs. (Creative Biolabs Authorized)

The Creative Biolabs' Advantages: Why Choose Our CRO Services?

  • Specialized Expertise: Our team comprises world-renowned scientists and researchers with deep expertise in microbiology, immunology, genomics, bioinformatics, and preclinical development specific to the microbiome field.
  • State-of-the-Art Facilities: We are equipped with cutting-edge laboratories, including anaerobic chambers, advanced sequencing platforms, and high-throughput screening capabilities, ensuring the highest quality and accuracy in your research.
  • Comprehensive Service Portfolio: From discovery to preclinical development, we tailor end-to-end solutions for your unique project requirements.
  • Accelerated Development: Our streamlined processes and efficient project management ensure timely delivery of results, helping you bring your microbiome innovations to clinical faster.
  • Unwavering Quality and Compliance: We adhere to the strictest quality standards, ensuring the integrity and credibility of your research.

Exploring the Frontiers: Application Scope of Microbiome Therapeutics Research

The potential applications of microbiome therapeutics are vast and continually expanding. Our research solutions support a wide range of therapeutic areas, including but not limited to:

  • Gastrointestinal Disorders: This is the most established and well-researched area for microbiome therapeutics due to the central role of the gut microbiome in digestive health.
  • Metabolic Disorders: The gut microbiome plays a significant role in metabolism, energy harvest, and fat storage.
  • Immune-Mediated Diseases: The microbiome's role in shaping immune tolerance makes it a target for autoimmune conditions.
  • Neurological and Psychiatric Conditions: The gut-brain axis, a bidirectional communication pathway, is a growing area of interest for microbiome therapeutics.
  • Infectious Diseases: Prevention and treatment of various bacterial and viral infections.
  • Oncology: Emerging research highlights the profound impact of the microbiome on cancer development, progression, and response to treatment.
  • Women's Health: The vaginal microbiome is critical for reproductive health and preventing infections. Research focuses on therapies for bacterial vaginosis and yeast infections.

The Imperative of Microbiome Research: Importance and Significance

The global health landscape faces unprecedented challenges, from the rise of antimicrobial resistance to the increasing prevalence of chronic diseases. Microbiome therapeutics offer a novel and sustainable approach to addressing these issues. By precisely modulating microbial communities, we can unlock new avenues for disease prevention, diagnosis, and treatment, leading to more personalized and effective healthcare solutions. This field represents a shift in the medical paradigm and is expected to completely change the way we understand and manage human health.

At Creative Biolabs, we are committed to scientific excellence, ethical practices, and delivering high-quality, actionable data. Our collaborative approach ensures that we are a true extension of your research team, working tirelessly to bring your microbiome therapeutic innovations to fruition.

Ready to unlock the potential of the microbiome? Contact us today to discuss your research needs and discover how our solutions can accelerate your journey.

Online Inquiry

For Research Use Only. Not intended for use in food manufacturing or medical procedures (diagnostics or therapeutics). Do Not Use in Humans.

Live Biotherapeutic


ISO 9001 Certified - Creative Biolabs Quality Management System.
Contact us

Copyright © 2025 Creative Biolabs. All Rights Reserved.

Inquiry Basket